Identifying Neddylation-modified features to assess prognosis and immune efficacy in hepatocellular carcinoma.
A cellular tagging system predicts which liver cancer patients will benefit from immunotherapy, improving treatment selection.
Liu Z et al. identified neddylation-modified features in hepatocellular carcinoma that correlate with prognosis and immune checkpoint inhibitor efficacy using multi-cohort bioinformatics analysis. These findings suggest neddylation as a potential biomarker for immunotherapy response stratification in HCC.
What the study was
- Study design
- Bioinformatics/multi-cohort retrospective analysis
- Population
- Hepatocellular carcinoma patients (multi-cohort analysis)
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Apoptosis
Why it surfaced
Neddylation as ICI biomarker in HCC is a novel angle on precision immunotherapy; bioinformatics study is exploratory but relevant to precision oncology watchlist.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.